Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 11, 2021
April 29 2021 - 6:55AM
Business Wire
Asensus Surgical, Inc. (NYSE American: ASXC), a medical device
company that is digitizing the interface between the surgeon and
patient to pioneer a new era of Performance-Guided Surgery™,
announced today that it plans to release 2021 first quarter
financial and operating results after the market closes on Tuesday,
May 11, 2021. The Company will host a conference call to discuss
these results starting at 4:30 p.m. ET the same day. The call will
be concurrently webcast.
To listen to the conference call on your telephone, please dial
1-855-327-6837 for domestic callers and 1-631-891-4304 for
international callers, and reference conference ID 10014229
approximately ten minutes prior to the start time. To access the
live audio webcast or archived recording, use the following link
https://ir.asensus.com/events-and-presentations. The replay will be
available on the Company’s website.
About Asensus Surgical, Inc.
Asensus Surgical, Inc. is digitizing the interface between the
surgeon and patient to pioneer a new era of Performance-Guided
Surgery by unlocking the clinical intelligence to enable
consistently superior outcomes and a new standard of surgery. This
builds upon the foundation of Digital Laparoscopy with the
Senhance® Surgical System powered by the Intelligent Surgical Unit™
(ISU™) to increase surgeon control and reduce surgical variability.
With the addition of machine vision, augmented intelligence, and
deep learning capabilities throughout the surgical experience, we
intend to holistically address the current clinical, cognitive and
economic shortcomings that drive surgical outcomes and value-based
healthcare. Learn more about Performance-Guided Surgery and Digital
Laparoscopy with the Senhance Surgical System here:
www.senhance.com. Now available for sale in the US, EU, Japan,
Russia, and select other countries. For a complete list of
indications for use, visit: www.senhance.com/indications. For more
information, visit www.asensus.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210429005152/en/
INVESTOR CONTACT: Mark Klausner or Mike Vallie,
443-213-0499 invest@asensus.com or MEDIA CONTACT: Kristin
Schaeffer CG Life kschaeffer@cglife.com
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Asensus Surgical, Inc. (NYSE:ASXC)
Historical Stock Chart
From Jul 2023 to Jul 2024